PlaqueTec

PlaqueTecPlaqueTec
PlaqueTec

PlaqueTec

Pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease.

Website
DR 15ActiveCambridge, United Kingdom
Rate
Advertise here

About

PlaqueTec is a medtech company focused on developing and utilizing intracoronary liquid biopsy to identify the inflammatory drivers of cardiovascular disease (CVD). They are building a proprietary cardiovascular data lake called BioCarta, which is a repository of unique intracoronary proteomic and clinical data.
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does PlaqueTec do?

PlaqueTec is a medtech company focused on developing and utilizing intracoronary liquid biopsy to identify the inflammatory drivers of cardiovascular disease (CVD). They are building a proprietary cardiovascular data lake called BioCarta, which is a repository of unique intracoronary proteomic and clinical data.

How much funding has PlaqueTec raised?

PlaqueTec has raised a total of $5M in funding. The most recent round on record is Funding Round.

Where is PlaqueTec headquartered?

PlaqueTec is headquartered in Cambridge, England, United Kingdom.

What industry does PlaqueTec operate in?

PlaqueTec operates in Biotechnology, Medical Devices, HealthTech, Artificial Intelligence.

What is PlaqueTec's revenue?

StartupHub estimates PlaqueTec's annual revenue at $640K (range $179K to $2.1M, 36% confidence), based on comparable companies in the sector.

What is PlaqueTec's valuation?

StartupHub estimates PlaqueTec's effective valuation at $18.4M (range $12.5M to $30.0M, 24% confidence), based on comparable companies in the sector.